Results 171 to 180 of about 54,505 (255)

Involuntary Clozapine Treatment: A Systematic Review

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 595-609, June 2026.
ABSTRACT Introduction We aimed to synthesize the information relevant for clinical practice on involuntary clozapine treatment. Methods Articles were identified with MEDLINE, Web of Sciences and PsycINFO search from inception through September 2025 (PROSPERO database registration CRD420251234475).
Hélène Verdoux, Alexis Lepetit, Peter F. J. Schulte   +2 more
wiley   +1 more source

Daunorubicin‐45 Vs. Daunorubicin‐60 for Induction in Intermediate‐Age Patients of AML: Results From a Randomized Trial

Cancer Science, Volume 117, Issue 6, Page 1690-1700, June 2026.
Daunorubicin dose escalation from 45 to 60 mg/m2 provides no clinical benefit for AML patients aged 55–65. A dose of 45 mg/m2 should remain the preferred regimen for this population. ABSTRACT Daunorubicin dose optimization remains crucial for AML treatment.
Chunlin Zhou, Le Li, Yan Li, Kaiqi Liu, Yuntao Liu, Dong Lin, Benfa Gong, Guangji Zhang, Xiaoyuan Gong, Qiuyun Fang, Bingcheng Liu, Shaowei Qiu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang   +15 more
wiley   +1 more source

Correlation Between Dosimetric Parameters and Hematologic Toxicity in Cervical Cancer Patients Undergoing Intensity-Modulated Pelvic Radiotherapy. [PDF]

Cancers (Basel)
Zhao S, Yang X, Zhang L, Yang D, Yang X, Wang R, Jia S, An J, Huang M.   +8 more
europepmc   +1 more source

Outcomes Following Alemtuzumab Induction in Deceased Donor Kidney Transplantation According to Recipient Age Categories: A Single Center Report

Clinical Transplantation, Volume 40, Issue 6, June 2026.
ABSTRACT Introduction The effects of induction therapy with the anti‐CD52 monoclonal antibody alemtuzumab on age‐specific outcomes following kidney transplantation (KT) remain inadequately studied. This study aimed to analyze the comparative safety and efficacy of single‐dose alemtuzumab induction in deceased donor (DD) KT recipients according to ...
Alex Ng, David I. Harriman, Alan C. Farney, Giuseppe Orlando, Colleen Jay, Amber Reeves‐Daniel, Robert J. Stratta   +6 more
wiley   +1 more source

Efficacy and safety of letermovir for cytomegalovirus prophylaxis in thoracic organ transplantation: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Aldalati AY, Hussein AM, Aldalati K, Hammadeh BM, Alrabadi B, Al-Dabagh A, Albliwi M, Abuassi M, Rawashdeh B.   +8 more
europepmc   +1 more source

A Randomized Trial to Investigate the Effects of Low‐Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT)

The Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.
ABSTRACT Hypertension is a prevalent and significant risk factor for cardiovascular disease (CVD). The immune system and inflammatory response are involved in the pathophysiology of hypertension. We hypothesize that treating hypertension with colchicine on top of standard therapy, will decrease pulse wave velocity (PWV), left ventricular mass, cardiac ...
Adam Femerling Langhoff, Niklas Dyrby Johansen, Marie Frimodt‐Møller, Ahmad Sajadieh, Tina Ken Schramm, Thomas A. Jepps, Tor Biering‐Sørensen   +6 more
wiley   +1 more source

Weekly cisplatin and nab-paclitaxel neoadjuvant chemoradiotherapy increases pathological complete response in locally advanced esophageal squamous cell carcinoma: A real-world study. [PDF]

Oncol Lett
Li L, Jing X, Niu J, Yi Y, Wang Y, Zhao K, Luo J, Yu J, Zhu H.   +8 more
europepmc   +1 more source

GATA2 Deficiency Syndrome: A Case Series and Literature Review. [PDF]

J Clin Immunol
Dong Z, Lai J, Li J, Du Y, Lin L, Chen R, Gong M, Zhuansun Y.   +7 more
europepmc   +1 more source

Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody-drug conjugate in breast cancer. [PDF]

Oncol Rev
Sofianidi AA, Papatheodoridi A, Dimitrakakis C, Marinopoulos S, Michalaki V, Zagouri F.   +5 more
europepmc   +1 more source

Misdiagnosis of oropouche virus in cancer patients: mimicry of treatment-related complications. [PDF]

Ann Med Surg (Lond)
Jamshed S, Danaf N.
europepmc   +1 more source